Icahn School of Medicine at Mount Sinai: Alzheimer Disease trials

The registry lists 13 Alzheimer Disease studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 1 are open to participants now and 3 have results posted.

Phase 2 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Fareon Open Label Device Clinical TrialNot yet recruitingNCT07600320Not applicable
• Using a Wireless Controller to Deliver a Lighting Intervention to Persons With DementiaCompletedNCT05519137Not applicableResults posted
• Understanding Circadian Responses to Light in Persons With Mild Cognitive ImpairmentCompletedNCT05411822Not applicableResults posted
• Riluzole in Mild Alzheimer's DiseaseCompletedNCT01703117Phase 2Results posted
• Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3CompletedNCT06595030Not applicable
• Resilient Together for DementiaCompletedNCT06421545Not applicable
• A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1CompletedNCT06356337Not applicable
• Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2CompletedNCT05837819Not applicable
• 7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild ADCompletedNCT05596994Not applicable
• Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)CompletedNCT04666077Not applicable
• The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive ImpairmentCompletedNCT04073628Not applicable
• Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2CompletedNCT03933696Not applicable
• Light and the Effect on Metabolic Syndrome and Alzheimer's DiseaseCompletedNCT03777722Not applicable